Generate a tailored SOP for Dr. Stefania Bellone. Improve your application with a focused, well-structured draft.
Stefania Bellone's research is published in high-impact journals within the cancer research field, including the New England Journal of Medicine, Cancer Research, and Clinical Cancer Research. Her translational research program on ovarian cancer has been funded by multiple federal agencies, including the Department of Defense and the National Institutes of Health, as well as private foundations. Currently, she is investigating the potential use of Clostridium Perfringens Enterotoxin (CPE) as a novel therapy for chemotherapy-resistant ovarian carcinoma. Bellone’s research encompasses a range of basic studies in molecular cancer genetics and tumor immunology, as well as translational clinical cancer research. She has initiated and completed several investigator-initiated FDA-approved clinical trials focusing on gynecologic patients, utilizing novel immunotherapeutic strategies developed in collaboration with Dr. Alessandro Santin's laboratory.
Yale University • New Haven, CT
Conducting research in obstetrics, gynecology, and reproductive sciences with a focus on cancer.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.